Reporting of sex- and age-specific outcomes for antibody drug conjugate-induced nausea and vomiting in patients with cancer
Purpose To evaluate how often studies of antibody drug conjugate-induced nausea and vomiting (ADCINV) report demographic characteristics and demographic-specific toxicity outcomes. Methods We conducted a secondary analysis of 202 studies included in a systematic review of ADCINV. We summarized study country and income setting, age and sex reporting, and whether nausea and vomiting outcomes were reported by age, sex, or country/region. Results Most studies were conducted in high-income settings (144/202, 71.3%). One hundred forty-eight studies (73.3%) reported at least one age summary, although only 22 (10.9%) reported an older-adult proportion. Overall, 123 studies (60.9%) reported the percentage of female participants. No study reported nausea or vomiting outcomes stratified by age, sex, or country/region. Conclusion ADC studies frequently report overall nausea and vomiting but do not provide the demographic-specific outcomes needed to evaluate differential risk. Standardized reporting by age, sex, and geographic setting is needed in future trials and real-world studies.
Authors
- Ronald Chow (ORCID: https://orcid.org/0000-0001-6195-8624)
- Jennifer Leigh (ORCID: https://orcid.org/0000-0002-7431-3574)
- Lawson Eng (ORCID: https://orcid.org/0000-0002-4816-8385)
- Maaz Syed (ORCID: https://orcid.org/0009-0002-1526-8221)
- Sumeet Talwar
- Samy Kannout
- Daniel Zhang
- Yigeng Tan
- Manu Beniwal
Institutions
- Alberta Health Services (CA)
- Sunnybrook Health Science Centre (CA)
- University Health Network (CA)
- University of Illinois Urbana-Champaign (US)
- University of Toronto (CA)
- Princess Margaret Cancer Centre (CA)
- University of Oxford (GB)
- Sunnybrook Hospital (CA)
- Odette Cancer Centre (CA)
Publication Details
- Journal
- Supportive Care in Cancer
- Published
- 2026-11-19
- DOI
- https://doi.org/10.1007/s00520-026-11508-x
- Primary Topic
- Nausea and vomiting management
- Type
- article
- Field-Weighted Citation Impact
- 0.00